HEAL Partners Announces Strategic Relationship with Elliott Investment Management and Launches US$500 Million Growth Fund II – Heavily Oversubscribed Fund I Closes

0

SYDNEY, April 05, 2022–(BUSINESS WIRE)–HEAL Partners, a global growth and tracking fund based in Australia and the Cayman Islands specializing in investments in the health, education and lifestyle sectors (“HEAL” ), announced today that it has signed a strategic relationship agreement with subsidiaries of Elliott Investment Management LP (“Elliott”). HEAL will launch its $350-500 million Fund II in the first half of 2022. As part of the strategic relationship, Elliott is expected to make a significant anchor commitment to HEAL’s Fund II.

This strategic relationship follows Elliott’s investment in January 2021 in Removery, the world’s largest tattoo removal company and a HEAL portfolio company founded by Mark Evans, Chris Chambers and Peter Chapman of HEAL Partners. Based in Austin, Texas, Removery has 90 studios in the United States, Canada and Australia and plans to open another 200 studios over the next two years.

Removery Founder and HEAL Partner Mark Evans said, “Elliott has been a great partner at Removery and we are delighted to build on this strong relationship through our future HEAL funds. On behalf of Elliott, Isaac Kim said, “We are excited about this strategic relationship with the HEAL team. We believe HEAL’s focus on delivering operational expertise and follow-on growth investment in strong business models, many of which were created by the team, is truly differentiated. Our collaboration through Removery underscores our confidence in HEAL’s active management approach and its ability to generate significant deal flow.

HEAL’s investment partners are Mark Evans and Chris Chambers of Normanby Capital, Peter Chapman and Martin Dalgleish of Asia Principal Capital and Martin Robinson.

HEAL is also backed by prominent industry leaders in healthcare and education, including Chris Rex (former CEO of Ramsay Healthcare), Stuart Giles and Cathie Reid (co-founders of Icon Group and Epic Pharmacy) and Rod Jones (Founder and Executive Chairman of Navitas), Dr. Andrew Meikle (Dental Corp Canada and The Fertility Partners) and Jonathan Sudharta (Halodoc) alongside other industry luminaries.

HEAL’s investment and advisory committees have collectively created more than $19 billion in shareholder value in the targeted HEAL sectors of healthcare and education.

HEAL launched Fund I in August 2020 with three foundational investments, demonstrating the caliber of high growth opportunities available to the Fund: Edge Early Learning Centers (Australia), Removery (Tattoo Removal, US) and Fertility Partners (IVF, Canada) and has made several other investments in the United States, Australia and Asia. Fund I closed heavily oversubscribed with A$140 million in commitments, exceeding its initial target of A$100 million. HEAL Partner, Martin Robinson, said: “We are very pleased with the composition and performance of the companies in our Fund 1 portfolio. We have committed the majority of our funds to date, with the remainder to be deployed in the portfolio. existing over the next six years. about months. We have seen several third-party investments in our portfolio companies at significant premiums to our initial entry prices. »

HEAL targets health, education and lifestyle assets that are high growth and globally and/or regionally scalable and has a strong commitment to ESG. In addition to creating its own opportunities, HEAL invests in later phases where it can be an active and engaged participant in the management and operation of the underlying asset.

“Since launching HEAL, we have been impressed by the large number of high quality and investment opportunities we have assessed, which demonstrates the seismic shifts underway in the HEAL sectors. For Fund II, we have a strong pipeline of exciting new opportunities in addition to the follow-up opportunities available at many of the companies in our Fund I portfolio,” concluded Robinson.

REMARKS:

About HEAL Partners
HEAL is an early growth stage acceleration investment vehicle focused on revenue-generating growth companies in the healthcare, education and lifestyle sectors with potential for global scale or disruption Of the industry. Led by a team of proven founders, investors, portfolio managers and traders, we are focused on capitalizing on the opportunities created by new specialties in developed markets.

Visit: www.healpartners.com

About Elliott
Elliott Investment Management LP manages approximately $51.5 billion in assets. Its flagship fund, Elliott Associates, LP, was founded in 1977, making it one of the oldest funds under continuous management. Investors in Elliott Funds include pension plans, sovereign wealth funds, endowments, foundations, funds of funds, high net worth individuals and families, and company employees.

See the source version on businesswire.com: https://www.businesswire.com/news/home/20220405005100/en/

contacts

Jack Gordon
Citadel-MAGNUS
[email protected]
+61 2 8234 0116 / 0478 060 362

Share.

About Author

Comments are closed.